← Back to Search

Behavioral Intervention

Digital Therapy for Smoking Cessation

N/A

Waitlist Available

Led By Jaimee Heffner

Research Sponsored by Fred Hutchinson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 3 months

Awards & highlights

Study Summary

This trial tests an online smoking cessation intervention designed for SGM young adults to help them quit smoking and reduce disparities in tobacco use.

Who is the study for?

This trial is for sexual and gender minority young adults aged 18-30 who smoke daily, have weekly internet access, are comfortable with English, and live in the US. They should be interested in quitting smoking for personal reasons and not currently using other cessation treatments.Check my eligibility

What is being tested?

The EQQUAL intervention is being tested to see if it helps SGM young adult smokers quit. It's an online program tailored to their needs that includes avatar-led therapy, questionnaires, health education, and support.See study design

What are the potential side effects?

Since this is a digital therapeutic involving educational content and questionnaires without medical or pharmaceutical interventions, no direct physical side effects are expected from participation.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

7-day point prevalence abstinence (PPA) from all nicotine and tobacco use

Acceptability of the EQQUAL avatar

Average change in Contemplation Ladder scores

+4 more

Secondary outcome measures

Changes in psychological flexibility

Changes in the acceptance of smoking triggers

Changes in valued living

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm I (EQQUAL A)Experimental Treatment3 Interventions

Participants receive self-guided online EQQUAL A program on study. Participants also receive motivational messages and smoking cessation information via text messages.

Group II: Arm II (EQQUAL B)Active Control3 Interventions

Participants receive self-guided online EQQUAL B program on study. Participants also receive motivational messages and smoking cessation information via text messages.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Fred Hutchinson Cancer CenterLead Sponsor

557 Previous Clinical Trials

1,343,390 Total Patients Enrolled

The Leonard and Norma Klorfine FoundationUNKNOWN

Jaimee HeffnerPrincipal InvestigatorFred Hutch/University of Washington Cancer Consortium

5 Previous Clinical Trials

501 Total Patients Enrolled

Media Library

Empowered, Queer, Quitting, and Living (EQQUAL) (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05847673 — N/A

Cancer Research Study Groups: Arm II (EQQUAL B), Arm I (EQQUAL A)

Cancer Clinical Trial 2023: Empowered, Queer, Quitting, and Living (EQQUAL) Highlights & Side Effects. Trial Name: NCT05847673 — N/A

Empowered, Queer, Quitting, and Living (EQQUAL) (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05847673 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the eligibility criterion of this study limited to a certain age group?

"In order to qualify for the trial, participants must not exceed 30 years of age and have reached the legal age of majority."

Answered by AI

Am I eligible to join this research project?

"This medical trial is seeking to enrol 120 participants that are between 18 and 30 years old, and have a positive diagnosis of cancer."

Answered by AI

Is enrollment in this experiment still open?

"At present, this clinical trial is not seeking any more enrolments. Initially posted on July 1st 2023 and most recently edited on April 27th 2023, there are 12 other experiments actively recruiting patients at the moment."

Answered by AI

What potential benefits are researchers hoping to uncover through this investigation?

"The purpose of this trial, conducted over a 3-month period, is to observe the decrease in cigarette consumption per day. Secondary results will be collected from assessments using both the Multidimensional Psychological Flexibility Inventory and Valuing Questionnaire. Statistical modelling with adjustment for stratification variables and any relevant baseline values that differ between study arms will also be applied. Lastly, there will be descriptive frequencies presented for participants who had high or low readiness to quit at baseline."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Avatar-Led Digital Therapeutic for Aiding Smoking Cessation in Sexual and Gender Minority Young Adults

2023. "Avatar-Led Digital Therapeutic for Aiding Smoking Cessation in Sexual and Gender Minority Young Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05847673.

All > Smoking Cessation